The field of atopic dermatitis (AD) has been receiving great interest over the last few years with the approvals of both oral ...

The U.S. Food and Drug Administration (FDA) announced the target action date of its review of the sNDA for VTAMA (tapinarof) cream, 1% has changed.

Atopic dermatitis can have a significant impact on quality of life in adolescents, so new efficient treatments are needed to ...

Dermavant Sciences has shared positive long-term results for its plaque psoriasis-approved Vtama (tapinarof) cream in adults ...

Eczema affects millions of Americans, and any number of environmental and health factors can trigger flare-ups. What should ...

Parents of children with atopic dermatitis (AD, also called eczema) know that the allergic condition can mean a heightened ...

Individuals who suffer from atopic dermatitis are three times more likely to develop anxiety, depression and sleep ...

Parents often try elimination diets to reduce food allergy risk in kids with eczema, but studies show limited results.

Long-term treatment of adolescents with moderate-to-severe atopic dermatitis with upadacitinib is safe and effective through 76 weeks.

Treatment with the Janus kinase (JAK) inhibitor upadacitinib (Rinvoq) showed a favorable long-term benefit-risk profile ...

A new study being presented at this year’s ACAAI Annual Scientific Meeting in Boston showed that elimination diets in the case of atopic dermatitis only mildly improved AD lesions in one-third of the ...

Learn about the benefits and risks of probiotic supplements and how to choose the best one for your health goals.